EMN
EASTMAN CHEMICAL CO
NYSE · Basic Materials · Chemicals - Specialty · US
$65.69
−0.83%Year over year
Reported trailing growth
- Revenue
- -4.5%
- EBITDA
- -26.3%
- EBIT
- -37.6%
- EPS
- -46.3%
- Free cash flow
- +31.8%
- Operating cash flow
- -1.1%
Forward estimates
Based on analyst estimates
- Revenue
- +5.9%
- EBITDA
- +33.3%
- EPS
- +74.3%
Three-year CAGR
- Revenue
- -6.0%
- EBITDA
- -7.6%
- EBIT
- -4.9%
- Net income
- -15.8%
- EPS
- -13.7%
- Free cash flow
- +5.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026